OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← Bladder Health UK

2025-03-31-accounts

REGISTERED COMPANY NUMBER: 08270007 (England and Wales) REGISTERED CHARITY NUMBER: 1149973

REPORT OF THE TRUSTEES AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

BLADDER HEALTH UK LIMITED

MDG Business Associates Limited Room 73 Wrest House Wrest Park Silsoe Bedfordshire MK45 4HR

BLADDER HEALTH UK LIMITED

CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

Page
Report of the Trustees 1 to 4
Independent Examiner's Report 5
Statement of Financial Activities 6
Balance Sheet 7
Notes to the Financial Statements 8 to 12

BLADDER HEALTH UK LIMITED

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 MARCH 2025

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES Objectives of the Charity

The objectives of the Charity are;

Public benefit

The Trustees of the Charity have due regard to the Charities Commission Guidance on public benefit. During the year ended March 2025, BHUK have provided the public with access to the advice line during weekdays, on-line forums, information via the website and social media via Facebook, Twitter and Instagram. The addition of Specialist Continence Nurses to the team has increased the volume of calls to the Advice Line and enhances the level of service offered by the Charity.

Our usage of social media continues to be significant, and we regularly interact with the general public and promote awareness through this medium. BHUK's bi-monthly newsletter has a distribution to members and our Healthcare Professional and Corporate database. This has continued to increase this year. We've also increased our number of educational events to sufferers and healthcare professionals.

ACHIEVEMENT AND PERFORMANCE

Bladder Health UK continued to support both patients/sufferers and healthcare professionals (HCP's) in 2024-25

We have continued to receive a large number of calls from sufferers who have not received all they would like from the NHS. Long waiting lists and lack of resource to explain treatments are just a couple of the reasons behind this.

The advice line is staffed weekly and receives a variety of bladder related calls both clinical and emotional.

Resources such as the condition handbooks are very popular and often taken by HCPs at study days to read for information and to pass on the charity details. This year, we have redesigned the diet handbook for patients. This is a very popular resource with sufferers and healthcare professionals.

The BHUK newsletter has been launched which replaces the magazine. This change will save significant costs and allow for easier accessibility and more regular contact. It is full of informative articles as well as a team and fundraiser news. It is a member resource, but copies are emailed to our HCP and corporate database.

Our events reputation has continued to increase. We consistently receive excellent feedback and event tickets sell well. We've increased the number of webinars we are hosting to increase the benefit to members who receive complimentary access and to offer increased education and engagement with our healthcare professional database. We are currently looking to launch an events page on our website to further promote these events. We have also organised study days and our flagship conference as well as regular events to promote the charity and raise awareness of its services.

The daily running of the charity is underpinned by good support systems. The administration and cost of these have continued to increase which has lead to a decision to change the membership model. The annual cost will change from a yearly subscription to a monthly subscription. This will allow us to continue to offer a membership and to coordinate sufferer webinars, social media post, groups and the newsletter.

The profile of BHUK has been raised and reinforced by our work with the National Institute for Health & Care Excellence (NICE). Members of the Bladder Health UK team have sat as 'expert patients' on NICE committees considering new treatments and devices and they have also taken part in a new initiative to engage with the Voluntary and Community sector. We are contributing to a number of research projects including with the Antibiotic Resistance Research Action group and with a project called VESPA.

Corporate and commercial sponsorship helps the charity to deliver all the much used and well-respected services every day and we are grateful to them for their continued support.

Page 1

BLADDER HEALTH UK LIMITED

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2025

FINANCIAL REVIEW

Reserves policy

The Board of Trustees has examined the Charity's requirements for reserves. It has established a policy whereby the unrestricted funds not committed or invested in tangible fixed assets held by the Charity should be a minimum of 6 and a maximum of 12 months of current expenditure. In light of prior difficulties arising from the aftermath of the recent unprecedented pandemic, the Trustees have decided to review the projections for the coming 18 months and has continued to set aside funds of £106,000 in a designated operational reserve for this purpose.

The annualised expenditure for 2024-2025 is £174,519. The reserves held exceed this figure in total funds of £180,034. The reserves are needed to meet the working capital requirement of the Charity and the Board of Trustees have taken a prudent approach regarding the foreseeable future operation of the Charity.

Operational review

The effects of inflation continue to affect the operations of Bladder Health UK. The key message is that management and Trustees have carefully considered the impact of inflation to ensure that these continue to reflect the financial needs and position of the charity for the foreseeable future.

We have reviewed outstanding payments and receipts, and adjustments have been made for invoices due but unpaid. We have reviewed debtors to ensure that the third parties remain in a position where they will be able to settle the amounts due. This is reflected in the accounts as 'Accruals' and 'Prepayments'. We anticipate the operational reserve of £106k and total restricted reserves will be maintained at the level agreed last year i.e £129k in order to ensure the operational reserve and funds are secure.

The Trustees' assessment on the Charity's ability to continue as a going concern is already a key area of emphasis and importance, and Trustees have continued to take account of the impact from the recent Coronavirus outbreak to ensure we have the appropriate disclosures. We have prepared and circulated projections for cash flow.

Going concern is projected for the foreseeable future. Our prudent approach would indicate no particular problems for the Charity moving forward. The Trustees will continue to monitor and review the financial situation on a regular basis.

Page 2

BLADDER HEALTH UK LIMITED

REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 MARCH 2025

STRUCTURE, GOVERNANCE AND MANAGEMENT

Bladder Health UK Ltd (BHUK) is a registered national charity No.1149973. Originally founded in 1994 the Charity operated under a Constitution document until its incorporation on 1st August 2013 to the newly formed charitable company limited by guarantee, was then known as The Cystitis and Overactive Bladder Foundation Ltd. The Charity then publicly changed its name on 1st January 2017 to become Bladder Health UK Ltd.

The Charity's governing document is its Memorandum and Articles of Association and the Trustees are the company directors. The Board of Trustees is elected by the Members at the annual general meeting. They serve a term of one year and must then retire and be re-elected if they wish to stand again for office.

The Board of Trustees take responsibility for the overall governance of the Charity, its activities, strategy, and financial planning, fundraising, investment, risk management and overall performance. The Trustees are committed to raising public and professional awareness of the charity's aims in order to promote its goals and mission. The Trustees meet two to four times each year and converse by email and telephone between board meetings. The internal Business Director is responsible for the day-to-day running of the charity and reports to the board of directors.

No Trustee received remuneration for their Trustee work during the year. Trustees may claim out of pocket expenses for activities related to fulfilling their role and responsibilities.

Details of Trustee expenses are disclosed within the statement of accounts. Trustees are required to disclose all relevant interests and register them with the Chairperson, and in accordance the Charity's policy, withdraw from decisions where a conflict of interest arises.

Under the Memorandum and Articles the Trustees on behalf of the Charity have the power to invest monies of the company which are not immediately required for its own purposes.

Recruitment of Directors/Trustees is carried out when necessary to maintain a diverse and skilled Board of Trustees to oversee the Charity business.New Directors/Trustees are firstly interviewed by the Chairperson and another board member. They are then inducted by attending one or two board meetings for assessment and approval of other board members and provided with following information;

The Charity structure is as follows;

REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number

08270007 (England and Wales)

Registered Charity number

1149973

Registered office

Kings Court 17 School Road Hall Green Birmingham West Midlands B28 8JG

Page 3

BLADDER HEALTH UK LIMITED

REPORT OF THE TRUSTEES

FOR THE YEAR ENDED 31 MARCH 2025

Trustees

M Bignall (resigned 18.6.2024) D Eaton - Chairperson J M Emkes N Fraser P M Latthe (Dr) K W Powell S Frier (resigned 16.11.2024) M A Grange - Treasurer

Independent Examiner

MDG Business Associates Limited Room 73 Wrest House Wrest Park Silsoe Bedfordshire MK45 4HR

Approved by order of the board of trustees on 7 June 2025 and signed on its behalf by:

D Eaton - Trustee

Page 4

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF BLADDER HEALTH UK LIMITED

Independent examiner's report to the trustees of Bladder Health Uk Limited ('the Company')

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2025.

Responsibilities and basis of report

As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Vicky Moore

MDG Business Associates Limited Room 73 Wrest House Wrest Park Silsoe Bedfordshire MK45 4HR

9 June 2025

Page 5

BLADDER HEALTH UK LIMITED

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2025

Unrestricted
Restricted
funds
funds
Notes
£
£
INCOME AND ENDOWMENTS FROM
Donations, legacies and charitable activities
116,910
-
Other income
2
15,245
-
Investment income
3
968
-
Total
133,123
-
EXPENDITURE ON
Raising funds
4
91,848
-
Charitable activities
Charitable activities
82,671
-
Total
174,519
-
NET INCOME/(EXPENDITURE)
(41,396)
-
RECONCILIATION OF FUNDS
Total funds brought forward
91,530
129,900
TOTAL FUNDS CARRIED FORWARD
50,134
129,900		 2025
Total
funds
£
116,910
15,245
968
133,123
91,848
82,671
174,519
(41,396)
221,430
180,034		 2024
Total
funds
£
172,980
20,575
3,568
197,123
88,754
73,677
162,431
34,692
186,738
221,430

The notes form part of these financial statements

Page 6

BLADDER HEALTH UK LIMITED

BALANCE SHEET

31 MARCH 2025

Unrestricted
Restricted
funds
funds
Notes
£
£
CURRENT ASSETS
Debtors
9
3,450
-
Cash at bank
50,526
129,900
53,976
129,900
CREDITORS
Amounts falling due within one year
10
(3,842)
-
NET CURRENT ASSETS
50,134
129,900
TOTAL ASSETS LESS CURRENT LIABILITIES
50,134
129,900
NET ASSETS
50,134
129,900
FUNDS
11
Unrestricted funds
Restricted funds
TOTAL FUNDS		 2025
Total
funds
£
3,450
180,426
183,876
(3,842)
180,034
180,034
180,034
50,134
129,900
180,034		 2024
Total
funds
£
11,868
211,002
222,870
(1,440)
221,430
221,430
221,430
91,530
129,900
221,430

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 7 June 2025 and were signed on its behalf by:

D Eaton - Trustee

M A Grange - Trustee

The notes form part of these financial statements

Page 7

BLADDER HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 20% on cost Computer equipment - 33% on cost

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits

The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

2. OTHER INCOME

OTHER INCOME
Fundraising - members
Membership fees		 2025
£
1,519
13,726
15,245		 2024
£
3,330
17,245
20,575

Page 8

BLADDER HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025

3. INVESTMENT INCOME

Bank interest received
RAISING FUNDS
Raising donations and legacies
Support costs		 2025
£
968
2025
£
91,848		 2024
£
3,568
2024
£
88,754

4. RAISING FUNDS

5. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.

Trustees' expenses

There were trustee expenses paid of £293 for the year ended 31 March 2025 (2024: £475).

6. STAFF COSTS

The average monthly number of employees during the year was as follows:

7.

Administration
No employees received emoluments in excess of £60,000.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations, legacies and charitable activities
172,980
Other income
20,575
Investment income
3,568
Total
197,123
EXPENDITURE ON
Raising funds
88,754
Charitable activities
Charitable activities
73,677
Total
162,431
NET INCOME
34,692
RECONCILIATION OF FUNDS
Total funds brought forward
56,838		 2025
5
Restricted
funds
£
-
-
-
-
-
-
-
-
129,900		 2024
4
Total
funds
£
172,980
20,575
3,568
197,123
88,754
73,677
162,431
34,692
186,738

Page 9

BLADDER HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025

7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
TOTAL FUNDS CARRIED FORWARD
91,530
129,900
8.
TANGIBLE FIXED ASSETS
Fixtures
and
Computer
fittings
equipment
£
£
Cost
At 1 April 2024 and 31 March 2025
5,000
20,835
Depreciation
At 1 April 2024 and 31 March 2025
5,000
20,835
Net book value
At 31 March 2025
-
-
At 31 March 2024
-
-
9.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025
£
Trade debtors
3,450
10.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025
£
Social security and other taxes
2,403
Accruals and deferred income
1,439
3,842
11.
MOVEMENT IN FUNDS
Net
movement
At 1.4.24
in funds
£
£
Unrestricted funds
General fund
91,530
(41,396)
Restricted funds
Regional work
8,900
-
Vision fund
15,000
-
Operational reserve
106,000
-
129,900
-
TOTAL FUNDS
221,430
(41,396)		 Total
funds
£
221,430
Totals
£
25,835
25,835
-
-
2024
£
11,868
2024
£
-
1,440
1,440
At
31.3.25
£
50,134
8,900
15,000
106,000
129,900
180,034		 Total
funds
£
221,430

Page 10

BLADDER HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025

11. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
TOTAL FUNDS		 Incoming
Resources
Movement
resources
expended
in funds
£
£
£
133,123
(174,519)
(41,396)
133,123
(174,519)
(41,396)

Comparatives for movement in funds

Unrestricted funds
General fund
Restricted funds
Regional work
Vision fund
Operational reserve
TOTAL FUNDS		 Net
movement
At 1.4.23
in funds
£
£
56,838
34,692
8,900
-
15,000
-
106,000
-
129,900
-
186,738
34,692		 At
31.3.24
£
91,530
8,900
15,000
106,000
129,900
221,430

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
TOTAL FUNDS		 Incoming
Resources
Movement
resources
expended
in funds
£
£
£
197,123
(162,431)
34,692
197,123
(162,431)
34,692

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
Restricted funds
Regional work
Vision fund
Operational reserve
TOTAL FUNDS		 Net
movement
At 1.4.23
in funds
£
£
56,838
(6,704)
8,900
-
15,000
-
106,000
-
129,900
-
186,738
(6,704)		 At
31.3.25
£
50,134
8,900
15,000
106,000
129,900
180,034

Page 11

BLADDER HEALTH UK LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025

11. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
TOTAL FUNDS		 Incoming
Resources
Movement
resources
expended
in funds
£
£
£
330,246
(336,950)
(6,704)
330,246
(336,950)
(6,704)

Regional work - groups providing support for people with bladder illness.

Vision fund - funding to update website and IT in forthcoming years.

12. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2025.

Page 12